Hennion & Walsh Asset Management’s Pacira BioSciences PCRX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.16M	Buy	203,520 +48,124	+31%	+$1.14M	0.15%	186
2026 Q1	$3.51M	Buy	155,396 +17,291	+13%	+$384K	0.12%	221
2025 Q4	$3.57M	Buy	138,105 +87,210	+171%	+$2.07M	0.12%	212
2025 Q3	$1.31M	Sell	50,895 -927	-2%	-$22.8K	0.05%	447
2025 Q2	$1.24M	Sell	51,822 -2,394	-4%	-$60.3K	0.05%	440
2025 Q1	$1.35M	Sell	54,216 -2,169	-4%	-$51.9K	0.06%	394
2024 Q4	$1.06M	Buy	56,385 +8,636	+18%	+$152K	0.05%	455
2024 Q3	$719K	Buy	47,749 +12,299	+35%	+$210K	0.03%	530
2024 Q2	$1.01M	Buy	+35,450	New	+$1.01M	0.05%	417
2021 Q4	–	Sell	-22,606	Closed	-$1.27M	–	778
2021 Q3	$1.27M	Sell	22,606 -3,640	-14%	-$210K	0.07%	310
2021 Q2	$1.59M	Buy	26,246 +61	+0.2%	+$3.86K	0.08%	274
2021 Q1	$1.83M	Buy	+26,185	New	+$1.87M	0.11%	247

Other funds holding PCRX

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return